SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Fagard Robert)
 

Search: WFRF:(Fagard Robert) > (2010) > Treatment of hypert...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Treatment of hypertension in patients 80 years and older : the lower the better? A meta-analysis of randomized controlled trials.

Bejan-Angoulvant, Theodora (author)
Saadatian-Elahi, Mitra (author)
Wright, James M (author)
show more...
Schron, Eleanor B (author)
Lindholm, Lars H (author)
Umeå universitet,Allmänmedicin
Fagard, Robert (author)
Staessen, Jan A (author)
Gueyffier, François (author)
show less...
 (creator_code:org_t)
2010
2010
English.
In: Journal of Hypertension. - 0263-6352 .- 1473-5598. ; 28:7, s. 1366-1372
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background: Results of randomized controlled trials are consistent in showing reduced rates of stroke, heart failure and cardiovascular events in very old patients treated with antihypertensive drugs. However, inconsistencies exist with regard to the effect of these drugs on total mortality. Methods: We performed a meta-analysis of available data on hypertensive patients 80 years and older by selecting total mortality as the main outcome. Secondary outcomes were coronary events, stroke, cardiovascular events, heart failure and cause-specific mortality. The common relative risk (RR) of active treatment versus placebo or no treatment was assessed using a random-effect model. Linear meta-regression was performed to explore the relationship between intensity of antihypertensive therapy and blood pressure (BP) reduction and the log-transformed value of total mortality odds ratios (ORs). Results: The overall RR for total mortality was 1.06 (95% confidence interval 0.89–1.25), with significant heterogeneity between hypertension in the very elderly trial (HYVET) and the other trials. This heterogeneity was not explained by differences in the follow-up duration between trials. The meta-regression suggested that a reduction in mortality was achieved in trials with the least BP reductions and the lowest intensity of therapy. Antihypertensive therapy significantly reduced (P < 0.001) the risk of stroke (35%), cardiovascular events (27%) and heart failure (50%). Cause-specific mortality was not different between treated and untreated patients. Conclusion: Treating hypertension in very old patients reduces stroke and heart failure with no effect on total mortality. The most reasonable strategy is the one associated with significant mortality reduction; thiazides as first-line drugs with a maximum of two drugs.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Keyword

80 and over
aged
antihypertensive therapy
heart failure
hypertension
intensity of therapy
meta-analysis
mortality
stroke

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view